| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |